Evidence map›Paper›PMID 42277298›Full record

ArticleNPJ precision oncology2026

Sequencing-free On-chip detection of lung cancer by fluorescent enzymatic profiling of cfDNA methylation.

Abed Agbarya, Noa Gilat, Yael Michaeli, Jasline Deek, Assaf Grunwald, Sivan Yogev, Lynne Itelson, Suheil Artul, Rasha Khoury, Michael Peled and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in NPJ precision oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Abed AgbaryaDepartment of Oncology, Bnai Zion Medical Center, Haifa, Israel.
Noa GilatSchool of Chemistry, Sackler Faculty of Exact Sciences, Tel Aviv University, Tel Aviv, Israel.
Yael MichaeliSchool of Chemistry, Sackler Faculty of Exact Sciences, Tel Aviv University, Tel Aviv, Israel.
Jasline DeekSchool of Chemistry, Sackler Faculty of Exact Sciences, Tel Aviv University, Tel Aviv, Israel.
Assaf GrunwaldSchool of Chemistry, Sackler Faculty of Exact Sciences, Tel Aviv University, Tel Aviv, Israel.
Sivan YogevSchool of Chemistry, Sackler Faculty of Exact Sciences, Tel Aviv University, Tel Aviv, Israel.
Lynne ItelsonJaxBio Technologies LTD, Netanya, Israel.
Suheil ArtulDepartment of Radiology, EMMS Hospital, Bar Ilan University Faculty of Medicine, Nazareth, Israel.
Rasha KhouryDepartment of Oncology, Bnai Zion Medical Center, Haifa, Israel.
Michael PeledInstitute of Pulmonary Medicine, Chaim Sheba Medical Center, Ramat Gan, Israel.
Yuval EbensteinSchool of Chemistry, Sackler Faculty of Exact Sciences, Tel Aviv University, Tel Aviv, Israel. uv@tauex.tau.ac.il.

Funding

European Innovation Council Accelerator grant 101188111European Research Council consolidator grant 817811Israel Science Foundation 771/21
6 · The paper itself

Abstract

We present a highly sensitive, low-cost approach for detecting lung cancer and monitoring response to therapy, based on sequencing-free detection of methylation biomarkers in cell-free DNA. After bisulfite treatment and PCR amplification of cell-free DNA, an engineered methyltransferase is used to fluorescently label all originally methylated CpG sites. Labeled cell-free DNA is then analyzed on a standard hybridization microarray. In a proof-of-concept lung cancer study involving 103 participants, we distinguished patients with cancer from healthy individuals with both sensitivity and specificity exceeding 90% for stage 2-4 lung cancer.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.